The CRUK Brain Tumour Conference brought together researchers at all levels to share their latest discoveries, build new partnerships, and discuss how to improve outcomes for people diagnosed with a brain tumour. The event saw three packed days of engaging talks, presentations, and panel discussions, all with a common goal — advancing research into brain tumours with patients at the centre.
A Multidisciplinary Approach
The brain tumour conference emphasised the importance of turning promising research into real treatments quickly. The program brought together experts from different areas of research into brain tumours and related fields, providing attendees with useful tools and techniques they could apply in their own work. Conversations centred on how researchers at various stages of their careers—whether in basic science, clinical trials, or applied research—can collaborate to better help people diagnosed with a brain tumour.
Encouraging Translation
Translational research is about turning scientific discoveries into real-world solutions that directly help people; forming a bridge between basic science and practical applications (such as treatments or interventions). The Brain Tumour Charity’s Chair of Translational Neuro-Oncology, Professor Petra Hamerlik, took part in a key panel discussion on translational research. One major area of conversation was the lack of accurate models that represent the complexity of brain tumours. The panellists discussed the use of preclinical models and how they often fall short of capturing the unique environment that brain tumours develop in, with particular reference to consideration of the blood-brain barrier, when developing new drugs. Panellists emphasised the need for more appropriate, representative models and drug development strategies tailored specifically to these challenges.
Our funded researchers
Several of our funded researchers attended the conference, including five of our Future Leaders.
Our Junior Fellow, Dr. Ty Miller, presented his research on glioblastoma, showcasing the potential that AI could have in shaping immunotherapy and tailoring treatments. You can read about Ty’s research here.
Our newly awarded Future Leader postdoctoral fellow, Dr. Emily Bates, shared her pioneering work on “smart viruses,” using viruses to target and destroy tumour cells, an example of how cutting-edge research is pushing boundaries. You can read more about Emily’s project here.
Accelerating a cure
The event united researchers and clinicians from across the field, building a collective path toward finding a cure and driving faster progress for the brain tumour community. At The Brain Tumour Charity, we are committed to improving the lives of everyone affected by a brain tumour. We work to amplify the community’s voice, and support research that aims to turn discoveries into life-saving treatments. Together, we’re working toward better care and brighter outcomes for all those facing this devastating diagnosis.